Share & more
Foreign currency shortages are hobbling Zimbabwe's efforts to treat thousands of HIV-positive people in urgent need of antiretroviral (ARV) drugs.
Acting director of the National Pharmaceutical Company, Charles Mwaramba, said his firm was struggling to meet public demand for ARVs as a result of the economic crisis.
According to the state-owned Herald newspaper, Mwaramba said: "There are 20,000 people on the national ARV rollout programme and we have less than a month's supply of the vital drugs, and that is not encouraging."
Official figures show that 1.6 million of the Southern African country's estimated 12 million people are living with HIV/AIDS.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions